Ivax Product Failure Tracking System Inadequate - FDA Warning Letter
Executive Summary
Ivax' product failure tracking system is inadequate, an FDA warning letter to the company states.
You may also be interested in...
Ivax Failure To Investigate Perphenazine Complaints Cited In Warning Letter
Ivax' quality unit failed to investigate eight complaints of discoloration for perphenazine tablets, FDA said in a warning letter.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011